SanBio has been granted a patent for a method and culture medium to induce polarization in multipotent stem cells, producing therapeutic cells and extracellular vesicles. The method involves using specific agents and ligands to induce expression of CXCL9 in the cells. GlobalData’s report on SanBio gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights SanBio Co Ltd - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on SanBio, NSAID cancer drugs was a key innovation area identified from patents. SanBio's grant share as of April 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.

Method for inducing polarization in stem cells for therapy